Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
about
Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosisPlasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cellsOsteoinductive factor inhibits formation of human osteoclast-like cellsType I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinLatent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding proteinProteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned mediumRole and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis modelThe Discovery and Early Days of TGF-β: A Historical PerspectiveInhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2.Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225).Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertensionInhibitory action of transforming growth factor beta on endothelial cells.New advances in the understanding of the pathophysiology of chronic venous insufficiency.Elevated cysteine-rich 61 mediates aberrant collagen homeostasis in chronologically aged and photoaged human skinDysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia.Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1.Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents.Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers.Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.Role of transforming growth factor-beta in the development of the mouse embryoThe opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cellsSome recent advances in the chemistry and biology of transforming growth factor-betaRegulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-betaGlucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populationsIn vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsRole of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.Transforming growth factor-beta: possible roles in carcinogenesis.Chemokines and chemokine receptors in scleroderma.Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development.Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide.
P2860
Q24295436-36A58C8D-D2FC-455B-BC14-1867A990C626Q24297830-6F02F520-383C-499D-95C7-A849B445BD29Q24558710-6550F36D-8E3D-4327-8F3E-2773CE78242EQ24612297-9CA6DB23-CC03-462E-AE65-416D71A3E6A7Q24673676-292ABBD1-B7CE-4F2E-894E-C913FE2AF3EEQ24679838-339D8EC6-1AB7-4109-B947-2661B22EC64CQ28142724-B7948486-1C81-472C-98F0-B5CD895734E4Q28276556-D2557392-C823-4817-9B23-4FC6EDD60FE3Q30724603-3CFF846C-C6D2-431B-BE7C-3A7049FDFFA0Q33937674-921866CD-DBA3-4178-8625-D217126B05DDQ34262965-E7CD0763-0F4E-4437-8D1F-CF19DEB8E4F6Q34337298-B1FF7864-EA6D-44D0-8C32-7E7A12FC9EB6Q34340081-1FE72197-7ABD-444D-8FC5-7D2A417E0A56Q35221977-F99BC581-58A4-40FE-B3C8-B83CBD0656ADQ35741406-01CB5AB9-3EEA-4A87-9ED4-D96EDBFC2FD6Q35796314-B797E115-3A9D-4F8F-866B-6864F9EC749CQ35811615-74BC7010-E5C1-4738-8DEE-5B4DC7D544D1Q35843492-6B41498B-BA90-4CD8-88C1-D9E1E89884D2Q35856553-02032C88-B83B-4907-A1C6-E0FCEB1A1FA8Q35861493-76C59764-83A3-4C86-8A8B-367FE4F80461Q36217085-239B43FF-9E4D-4AA5-895F-E2D92EAE707DQ36217216-7FC019AD-1400-4287-B33F-77F51561F55EQ36217451-DCE184BA-A934-4EBD-9B4E-BA8095C072DFQ36217584-4F3C9B25-A740-4916-A86C-0DA6889DBAF6Q36218283-0C664155-4BD7-4C89-A7E3-4194CF7031D6Q36218668-619AD748-FDCD-4619-8E1D-D88068D6650AQ36218832-EB4233D9-8941-491E-BCB7-DACC5A4EDE17Q36220034-5B3A2529-EEE1-4129-BC49-41AF27AA025EQ36222413-8B41833D-D254-4B47-8889-ACC94F71AE49Q36222838-6B313A76-7F19-40B4-B661-74AF84AAA697Q36223446-3FD2345B-A863-464F-AEB0-1EC61625E62AQ36223450-64289EC9-B38C-4718-BEA3-C9C7D32173EFQ36223752-22F59175-402B-4DC9-9A54-55D58BD6AE9EQ36223980-2FE3AA37-39AD-4C63-B204-BE8E79E67EAEQ36232642-A804D6CD-42B6-4309-8AE9-6059BCEBDFBBQ36383054-D29359B5-A94F-402D-9DA6-3FC7BE5002B2Q36465897-7F9EA572-7D10-4CA8-BE38-407CE59D0F6FQ36521144-4F0F3A68-7801-47CA-B990-5D467D1A9F6CQ36620077-C1FB80BA-F5B8-4180-AF93-319D50A2F28CQ36720977-6B1ECB4A-7346-4CF6-904D-E0D9D34AFC87
P2860
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Enhanced production and extrac ...... ansforming growth factor-beta.
@ast
Enhanced production and extrac ...... ansforming growth factor-beta.
@en
type
label
Enhanced production and extrac ...... ansforming growth factor-beta.
@ast
Enhanced production and extrac ...... ansforming growth factor-beta.
@en
prefLabel
Enhanced production and extrac ...... ansforming growth factor-beta.
@ast
Enhanced production and extrac ...... ansforming growth factor-beta.
@en
P2093
P2860
P356
P1476
Enhanced production and extrac ...... ansforming growth factor-beta.
@en
P2093
Andreasen PA
Keski-Oja J
P2860
P304
P356
10.1083/JCB.103.6.2403
P407
P433
P577
1986-12-01T00:00:00Z